Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6–35 Months: A Randomized, Controlled Trial

Documenti analoghi

• A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age
  di: Pavia-Ruz, Noris, et al.
  Pubblicazione: (2013)
• Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6–35 Months of Age During 2013–2014: Results From A Phase II Randomized Trial
  di: Wang, Long, et al.
  Pubblicazione: (2016)
• Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012–2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial
  di: Langley, Joanne M., et al.
  Pubblicazione: (2015)
• Safety and immunogenicity of 3 seasonal trivalent influenza vaccines in the Chinese military
  di: Gao, Dongqi, et al.
  Pubblicazione: (2016)
• A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months
  di: Carmona Martinez, Alfonso, et al.
  Pubblicazione: (2014)